{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/strategically-supporting-sample-collection-and-cancer-screening-phase-iii-mega-trial#webpage",
"url": "https://www.fortrea.com/insights/strategically-supporting-sample-collection-and-cancer-screening-phase-iii-mega-trial",
"name": "Strategically supporting sample collection and cancer screening in a Phase III mega trial",
"description": "This Fortrea case study explores how a Phase III cancer screening trial was executed through coordinated patient recruitment, sample management, and multi-site clinical trial operations across large-scale screening activities. The study involved operational complexity related to site selection, pre-study visits, contract management, oncology patient recruitment, and clinical trial blood sample management within an early cancer detection clinical study program. The case study highlights challenges related to large-scale patient recruitment for clinical trials, diversity enrollment in clinical trials, screening trial logistics, and maintaining operational efficiency across multiple study locations. Fortrea implemented structured site relationship management, patient enrollment strategy planning, and operational coordination processes to support biospecimen collection, site-level activities, and continuity across clinical trial operations. By integrating large-scale clinical trial management solutions with patient recruitment, sample management, and site support workflows, the approach strengthened operational continuity and supported successful execution of the Phase III cancer screening trial."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Strategically supporting sample collection and cancer screening in a Phase III mega trial",
"item": "https://www.fortrea.com/insights/strategically-supporting-sample-collection-and-cancer-screening-phase-iii-mega-trial"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/strategically-supporting-sample-collection-and-cancer-screening-phase-iii-mega-trial#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/strategically-supporting-sample-collection-and-cancer-screening-phase-iii-mega-trial#webpage"
},
"headline": "Executing a Phase III Cancer Screening Trial Through Large-Scale Patient Recruitment and Sample Management | Fortrea Case Study",
"description": "This Fortrea case study explores how a Phase III cancer screening trial was executed through coordinated patient recruitment, sample management, and multi-site clinical trial operations across large-scale screening activities. The study involved operational complexity related to site selection, pre-study visits, contract management, oncology patient recruitment, and clinical trial blood sample management within an early cancer detection clinical study program. The case study highlights challenges related to large-scale patient recruitment for clinical trials, diversity enrollment in clinical trials, screening trial logistics, and maintaining operational efficiency across multiple study locations. Fortrea implemented structured site relationship management, patient enrollment strategy planning, and operational coordination processes to support biospecimen collection, site-level activities, and continuity across clinical trial operations. By integrating large-scale clinical trial management solutions with patient recruitment, sample management, and site support workflows, the approach strengthened operational continuity and supported successful execution of the Phase III cancer screening trial.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-02-14",
"dateModified": "2026-02-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-01/phase-3-cancer-screening-mega-trial.pdf",
"encodingFormat": "application/pdf"
}
}
]
}